A medical worker takes out the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot from a cooler at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
A medical worker administers a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot to a resident at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
A medical worker prepares to administer a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
A medical worker administers a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot to a resident at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
A medical worker prepares to administer a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
A medical worker shows the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot at a temporary vaccination cite in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
